Spyre Therapeutics (SYRE) Q3 2016 Earnings

8NovExpected
Q1 2016
Q2 2016
Q3 2016
-177.42
-118.43
-59.43
-0.43

Details

Expected EPS
-0.55
Actual EPS
-0.47
Surprise EPS
0.08
Surprise Percent
+14.55%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.47 per share for Q3 2016.

0 Comments

Share your thoughts